|
|
Reference
|
|
   
|
Abdulrab, K., Heun, R. (2008) Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. European psychiatry, 23(5): 321-30
|
|
|
Artero, S., Petersen, R., Touchon, J., Ritchie, K. (2006) Revised Criteria for Mild Cognitive Impairment: Validation within a Longitudinal Population Study. Dementia and Geriatric Cognitive Disorders, 22(5-6): 465-470
|
|
|
Ban, J.Y., Seong, Y.H. (2005) Blockade of 5-HT3 receptor with MDL72222 and Y25130 reduces β-amyloid protein (25-35)-induced neurotoxicity in cultured rat cortical neurons. European Journal of Pharmacology, 520(1-3): 12-21
|
|
|
Bentue'-Ferrer, D., Allain, H. (2006) Medicaments avisee antiamyloide. L Anne e Gerontologique, 20: 76-83
|
|
|
Brodaty, H., Heffernan, M., Kochan, N.A., Draper, B., Trollor, J.N., Reppermund, S., Slavin, M.J., Sachdev, P.S. (2013) Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study. Alzheimer's and Dementia, 9(3): 310-317.e1
|
|
|
Brodaty, H., Low, L., Gibson, L., Burns, K. (2006) What is the best dementia screening instrument for general practitioners to use?. American journal of geriatric psychiatry, 14(5): 391-400
|
|
|
Department of health (2009) Living well with dementia: National dementia strategy. London, Dostupno na: https://www.gov.uk/government/uploads/ system/uploads/attachment_data/ file/168221/dh_094052.pdf
|
|
|
Dichgans, M., Zietemann, V. (2012) Prevention of vascular cognitive impairment. Stroke, 43(11): 3137-46
|
|
|
Dlugaj, M., Weimar, C., Wege, N., Verde, P.E., Gerwig, M., Dragano, N., Moebus, S., Jöckel, K., Erbel, R., Siegrist, J. (2010) Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort. Dementia and geriatric cognitive disorders, 30(4): 362-73
|
|
|
Doglio, L.E., Kanwar, R., Jackson, G.R., Perez, M., Avila, J., Dingwall, C., Dotti, C.G., Fortini, M.E., Feiguin, F. (2006) gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. Neuron, 50(3): 359-75
|
|
|
Dysken, M.W., Sano, M., Asthana, S., Vertrees, J.E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G.D., McCarten, J., Malphurs, J., Prieto, S., Chen, P., Loreck, D.J., Trapp, G., Bakshi, R.S. (2014) Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA, 311(1): 33-44
|
|
|
Jacova, C., Kertesz, A., Blair, M., Fisk, J.D., Feldman, H.H. (2007) Neuropsychological testing and assessment for dementia. Alzheimer's and dementia, 3(4): 299-317
|
|
|
Keller, A.J., Sherman, E.M.S., Strauss, E. (2011) Blessed Dementia Scale. Encyclopedia of Clinical Neuropsychology, str. 413-415
|
|
2
|
Levey, A., Lah, J., Goldstein, F., i dr. (2006) Mild cognitive impairment: An opportunity to identify patients at high risk for progression to Alzheimer's disease. Clinical Therapeutics, 28(7): 991
|
|
|
Lopez, O.L., Becker, J.T., Jagust, W.J. (2006) Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry, 77(2):159-65
|
|
|
Luck, T., Riedel-Heller, S.G., Kaduszkiewicz, H., Bickel, H., Jessen, F., Pentzek, M., Wiese, B., Koelsch, H., van den Bussche, H., Abholz, H., Moesch, E., Gorfer, S., Angermeyer, M.C. (2007) Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dementia and geriatric cognitive disorders, 24(4): 307-16
|
|
3
|
Nasreddine, Z.S., Phillips, N.A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J.L., Chertkow, H. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4): 695-9
|
|
|
Panza, F., Capurso, C., D`Introno, A., Colacicco, A.M., Zenzola, A., Menga, R., Pistoia, G., Santamato, A., Scafato, E., Gandin, C., Capurso, A., Solfrizzi, V. (2008) Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. International Journal of Geriatric Psychiatry, 23(7): 726-734
|
|
1
|
Perneczky, R., Wagenpfeil, S., Komossa, K., Grimmer, T., Diehl, J., Kurz, A. (2006) Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia Rating. American Journal of Geriatric Psychiatry, 14(2): 139-144
|
|
1
|
Petersen, R.C. (2004) Mild cognitive impairment as a diagnostic entity. Journal of internal medicine, 256(3): 183-94
|
|
|
Petit, D., Gagnon, J., Fantini, M.L., Ferini-Strambi, L., Montplaisir, J. (2004) Sleep and quantitative EEG in neurodegenerative disorders. Journal of psychosomatic research, 56(5): 487-96
|
|
|
Slavin, M.J., Brodaty, H., Kochan, N.A., Crawford, J.D., Trollor, J.N., Draper, B., et al. (2010) Prevalence and predictors of ‘subjective cognitive complaints' in the Sydney memory and ageing study. Am J Geriatr Psychiatry, 18(8); 701-10
|
|
|
Taniguchi, M., Okayama, Y., Hashimoto, Y., Kitaura, M., Jimbo, D., Wakutani, Y., Wada-Isoe, K., Nakashima, K., Akatsu, H., Furukawa, K., Arai, H., Urakami, K. (2008) Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders, 26(2): 117-122
|
|
1
|
Uttara, B., Singh, A., Zamboni, P., Mahajan, R. (2009) Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options. Current Neuropharmacology, 7(1): 65-74
|
|
|
Wahlund, L., Pihlstrand, E., Jonhagen, M.E. (2003) Mild cognitive impairment: experience from a memory clinic. Acta Neurologica Scandinavica, 107(s179): 21-24
|
|
|
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., Nordberg, A., Backman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., de Leon, M., Decarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., Jack, C., Jorm, A. (2004) Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256(3): 240-246
|
|
|
|
|